[Does a specific withdrawal syndrome from non-dopaminergic antiparkinson agents exist?].
V
V
George
A
A
Castot
I
I
Bidault
D000328:Adult; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D008297:Male; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*; D014282:Trihexyphenidyl / Q000009:adverse effects
D000978:Antiparkinson Agents; D014282:Trihexyphenidyl
Existe-t-il un syndrome de sevrage spécifique aux antiparkinsoniens non dopaminergiques?